Banner Life Sciences
WEBApr 30, 2020 · Banner Life Sciences combines a proven history of formulation expertise with proprietary technologies to create specialty pharmaceuticals that solve real unmet clinical needs.
BAFIERTAM® (monomethyl fumarate) | Relapsing MS Treatment
WEBBAFIERTAM is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. It is not known if BAFIERTAM is safe and effective in children.
Banner Life Sciences Announces Final FDA Approval of …
WEBApr 30, 2020 · “The FDA’s final approval marks an important milestone for Banner and for patients living with relapsing-remitting multiple sclerosis,” said Franck Rousseau, M.D., Chief Executive Officer of Banner.
FDA Approves Banner’s Multiple Sclerosis Drug
WEBApr 30, 2020 · Banner Life Sciences, a privately held specialty pharmaceutical company based in High Point, has gained final regulatory approval of a drug for treating multiple sclerosis.
Banner Life Sciences Announces Commercial Launch of
WEBJul 16, 2020 · HIGH POINT, N.C.-- ( BUSINESS WIRE )--Banner Life Sciences LLC (Banner), a privately held specialty pharmaceutical company, today announced that BAFIERTAM™ (monomethyl fumarate), a novel...
Banner Life Sciences Announces BAFIERTAM, a Novel Oral …
WEBSep 3, 2020 · HIGH POINT, N.C.-- ( BUSINESS WIRE )--Banner Life Sciences LLC (Banner), a privately held specialty pharmaceutical company, today announced that BAFIERTAM™ (monomethyl fumarate), a novel...
Banner Life Sciences - LinkedIn
WEBOverview Banner Life Sciences LLC, a privately-held clinical-stage pharmaceutical company, combines a proven history of formulation expertise with proprietary technologies to create specialty...
FDA Approves Bafiertam, Tecfidera Bioequivalent, for Relapsing …
WEBMay 5, 2020 · The U.S. Food and Drug Administration (FDA) has given final approval to Banner Life Sciences’ Bafiertam (monomethyl fumarate), a bioequivalent alternative to Biogen’s Tecfidera (dimethyl...
About - Banner Life Sciences
WEBBanner Life Sciences combines a proven history of formulation expertise with proprietary technologies to create specialty pharmaceuticals that solve real unmet clinical needs.
High Point pharma firm secures FDA approval for multiple …
WEBMay 1, 2020 · Banner Life Sciences, a privately held specialty pharmaceutical company based in High Point, has gained final regulatory approval of a drug for treating multiple sclerosis.
- Some results have been removed
Skip to content